otc drugs

NEW RULES FOR ADMINISTRATIVE PROCESSING OF DIN SUBMISSIONS COMING MARCH 1, 2018 By: Teri Dickinson, Manager, Regulatory Affairs Group, email On December 13, 2017 Health Canada... Read More

Fee Proposal for Drugs and Medical Devices Published for Consultation By: Teri Dickinson Jenner, Manager, Regulatory Affairs Group, email Budget 2017 signalled the Government of Canada’s... Read More

Updating Canada’s PLL Regulations By: Vicki Schofield, Regulatory Affairs Specialist, email Beginning June 13, 2017, Plain Language Labelling Regulations came into effect for non-prescription drugs.  The intention of... Read More

By: Joe McCarthy, Senior regulatory Affairs Specialist, email Environment Canada has published a proposed amendment that 5 MDI substances (101-68-8; 2536-05-2, 5873-54-1; 9016-87-9 and 26447-40-5) be... Read More

Updating Canada’s Natural Health Products Regulations By: Vicki Schofield, Regulatory Affairs Specialist, email Natural Health Products have been in the news recently as Health Canada works to... Read More

By: Vicki Schofield, Regulatory Affairs Specialist, email Canada’s unique regulatory system can appear daunting at a first glance, especially if a company would like to bring... Read More

By: Vicki Schofield, Regulatory Affairs Specialist, email Proactively self auditing labels, particularly with registered products issued with DIN or NPN numbers can save headaches down the... Read More

Topical Products Containing Menthol Required Label Updates By: Teri Jenner, Manager Regulatory Affairs Group, email A safety review was recently carried out by Health Canada on... Read More